Home » Authors » Catherine Shaffer

Articles by Catherine Shaffer

NewCo News: Del Mar Pharma Bets on Glioblastoma Salvage Therapy

Aug. 17, 2010

By Catherine Shaffer

CeNeRx Hits Phase II Home Stretch with $13M Series C

Aug. 16, 2010

By Catherine Shaffer

NewCo News: Valocor says 'Beat It' to Acne, Atopic Dermatitis and Vitiligo

Aug. 13, 2010

By Catherine Shaffer

Dicerna Raises $25M Series B to Fund RNAi Cancer Program

Aug. 12, 2010

By Catherine Shaffer

Tetralogic Coasts into Clinic with $32M Financing

Aug. 11, 2010

By Catherine Shaffer

NewCo News: Sirnaomics Takes Multitarget Approach to Gene Silencing

Aug. 10, 2010

By Catherine Shaffer

Trius' IPO Low Like Others, but Window Could Be Near

Aug. 9, 2010

By Catherine Shaffer

NewCo News: Senex Targets Aging Diseases with CKI Pathway Inhibitors

Aug. 6, 2010

By Catherine Shaffer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026